Evidence map›Paper›PMID 7623841›Full record

ArticleMolecular and cellular biology1995

A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB.

E Hadzic, V Desai-Yajnik, E Helmer, S Guo, S Wu, N Koudinova, J Casanova, B M Raaka, H H Samuels

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

E HadzicDepartment of Cell Biology, New York University Medical Center, New York 10016, USA.
V Desai-Yajnik
E Helmer
S Guo
S Wu
N Koudinova
J Casanova
B M Raaka
H H Samuels
New York University · USColumbia University Irving Medical Center · US

Funding

METABOLIC EFFECTS OF THYROID HORMONE IN CELL CULTURER01DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1986 to 2007
$6.0M
GRADUATE PROGRAM IN CELLULAR &MOLECULAR BIOLOGYT32GM007238 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RIFKIN, DANIEL B · 1985 to 2013
$2.7M
SHORT-TERM TRAINING: STUDENTS IN HEALTH PROFESSIONAL SCHT35DK007421 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RAMASAMY, RAVICHANDRAN · 1985 to 2023
$2.5M
Metabolic Effects of Thyroid HormoneR56DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 2009 to 2009
$211k
METABOLIC EFFECTS OF THYROID HORMONER37DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1991 to 1998
–
NIDDK NIH HHS 5T35DK07421NIDDK NIH HHS DK16636NIGMS NIH HHS GM07238
6 · The paper itself

Abstract

The effects of the thyroid hormone (3,5,3'-triiodo-L-thyronine [T3]) on gene transcription are mediated by nuclear T3 receptors (T3Rs). alpha- and beta-isoform T3Rs (T3R alpha and -beta) are expressed from different genes and are members of a superfamily of ligand-dependent transcription factors that also includes the receptors for steroid hormones, vitamin D, and retinoids. Although T3 activates transcription by mediating a conformational change in the C-terminal approximately 220-amino-acid ligand-binding domain (LBD), the fundamental mechanisms of T3R-mediated transcriptional activation remain to be determined. We found that deletion of the 50-amino-acid N-terminal A/B domain of chicken T3R alpha (cT3R alpha) decreases T3-dependent stimulation of genes regulated by native thyroid hormone response elements about 10- to 20-fold. The requirement of the A/B region for transcriptional activation was mapped to amino acids 21 to 30, which contain a cluster of five basic amino acids. The A/B region of cT3R alpha is not required for T3 binding or for DNA binding of the receptor as a heterodimer with retinoid X receptor. In vitro binding studies indicate that the N-terminal region of cT3R alpha interacts efficiently with TFIIB and that this interaction requires amino acids 21 to 30 of the A/B region. In contrast, the LBD interacts poorly with TFIIB. The region of TFIIB primarily involved in the binding of cT3R alpha includes an amphipathic alpha helix contained within residues 178 to 201. Analysis using a fusion protein containing the DNA-binding domain of GAL4 and the entire A/B region of cT3R alpha suggests that this region does not contain an intrinsic activation domain. These and other studies indicate that cT3R alpha mediates at least some of its effects through TFIIB in vivo and that the N-terminal region of DNA-bound cT3R alpha acts to recruit and/or stabilize the binding of TFIIB to the transcription complex. T3 stimulation could then result from ligand-mediated changes in the LBD which may lead to the interaction of other factors with cT3R alpha, TFIIB, and/or other components involved in the initiation of transcription.

Indexed as

Gene Expression RegulationTranscription, GeneticAmino Acid SequenceAnimalsBlotting, WesternCells, CulturedConserved SequenceDNA Mutational AnalysisHumansLigandsMolecular Sequence DataProtein BindingReceptors, Thyroid HormoneRecombinant Fusion ProteinsStructure-Activity RelationshipTranscription FactorsLigandsReceptors, Thyroid HormoneRecombinant Fusion ProteinsTranscription FactorsTranscription Factor TFIIBTriiodothyronine

Identifiers

PMID7623841
PMCPMC230690
OpenAlexW2098464529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.